secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001628280-23-033545
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven establishes $150M at-the-market equity offering program with J.P. Morgan
--------------------------------------------------------------------------------

- Agreement with J.P. Morgan Securities allows sale of up to $150M common shares via ATM program.
- Sales may occur on NYSE at prevailing market prices or in negotiated transactions.
- Company may sell shares periodically based on market conditions, capital needs, and other factors.
- Registration statement on Form S-3 filed October 2, 2023 (File No. 333-274822).
- Program provides added flexibility for potential future financing without immediate dilution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000162828023033545/0001628280-23-033545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000162828023033545/bhvn-20231002.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-033545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer